-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$2.0092.31% Upside
Achilles Therapeutics plc Frequently Asked Questions
-
What analysts cover Achilles Therapeutics plc?
Achilles Therapeutics plc has been rated by research analysts at Piper Sandler in the past 90 days.